Company Profile
Cel-Sci Corporation Stock Price, News & Catalysts
- Ticker:
- CVM
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.55 USD (+0.65%)
Close
Last updated: August 17, 2026
21.6M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, CVM closed up 0.65% at $1.55. No new same-company headline was identified in the current news window.
Company overview
Business overview
Cel-Sci is a biotechnology company focused on immunotherapy and cancer vaccine approaches. Its story has long centered on a high-risk, high-conviction immune-oncology platform.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE American, Cel-Sci sits in oncology biotechnology.
Business Model Characteristics
The company depends on clinical validation, regulatory progress, and the ability to create a differentiated immunotherapy story.
Position Within the Biotechnology Landscape
Cel-Sci is a classic high-beta oncology name whose stock is extremely sensitive to trial outcomes.
Future catalysts
- Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event. The company’s stock remains highly event-driven.
Recent news
- 01
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cel-Sci Corporation (CVM)?
Cel-Sci Corporation (CVM) most recently closed at 1.55 USD, a +0.65% move versus the previous session.
What is the market cap of Cel-Sci Corporation (CVM)?
Cel-Sci Corporation currently has a market capitalization of 21.6M USD on BioPharmSignal.
What does Cel-Sci Corporation do?
Cel-Sci is a biotechnology company focused on immunotherapy and cancer vaccine approaches. Its story has long centered on a high-risk, high-conviction immune-oncology platform.
On which exchange is CVM stock listed?
Cel-Sci Corporation (CVM) is associated with AMEX, United States, Biopharma.
What is Cel-Sci?
Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event.
Which conditions is Cel-Sci Corporation targeting with Cel-Sci?
Cel-Sci Corporation is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Cel-Sci Corporation describe recent progress with Cel-Sci?
Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event.
What is Multikine-related?
Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event.